DailyStocks Stock Article Search

https://seekingalpha.com/news/4066452-lyft-sees-full-year-free-cash-flow-positivity-for-first-time-stock-rockets-after-hours?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Feb 13, 2024 - Lyft (LYFT) on Tuesday said it would generate positive free cash flow for a full year for the first time. Read more here. 0

https://www.zacks.com/stock/news/2225835/amc-entertainment-amc-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2225835 Feb 13, 2024 - In the latest trading session, AMC Entertainment (AMC) closed at $4.49, marking a -1.54% move from the previous day. 0

https://www.zacks.com/stock/news/2225634/what-s-in-store-for-zebra-technologies-zbra-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2225634 Feb 13, 2024 - Weakness in the Enterprise Visibility & Mobility segment and forex woes are likely to hurt Zebra Technologies' (ZBRA) fourth-quarter performance. 0

https://www.zacks.com/stock/news/2224816/wall-street-analysts-see-a-39-25-upside-in-altus-power-inc-amps-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2224816 Feb 12, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 39.3% in Altus Power, Inc. (AMPS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2224738/what-s-in-the-offing-for-howmet-hwm-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2224738 Feb 12, 2024 - Strength in the Engine products segment due to growth in the commercial aerospace, defense aerospace and industrial gas turbine markets is likely to aid Howmet's (HWM) fourth-quarter 2023 results. 0

https://www.zacks.com/stock/news/2224151/wall-street-analysts-see-a-33-27-upside-in-edgewise-therapeutics-inc-ewtx-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2224151 Feb 09, 2024 - The mean of analysts' price targets for Edgewise Therapeutics, Inc. (EWTX) points to a 33.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. 0

https://www.rttnews.com/story.aspx?Id=3423607 Feb 09, 2024 - The major U.S. index futures are currently pointing to a higher open on Friday, with stocks likely to add to the modest gains seen at the close of yesterday's lackluster session. 0

https://seekingalpha.com/news/4064942-ubs-starts-axsome-at-buy-sees-auvelity-hitting-1b-sales-by-2030?source=feed_sector_healthcare Feb 08, 2024 - UBS has initiated coverage of Axsome Therapeutics (AXSM) with a buy rating, commenting that it was bullish on the launch of the company’s drug Auvelity and upco 0

https://www.zacks.com/stock/news/2222607/wall-street-analysts-see-a-36-75-upside-in-hudbay-minerals-hbm-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2222607 Feb 07, 2024 - The mean of analysts' price targets for HudBay Minerals (HBM) points to a 36.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. 0

https://www.rttnews.com/story.aspx?Id=3421850 Feb 05, 2024 - (Adds Outlook) 0